Lifetime cost-effectiveness of calcineurin inhibitor withdrawal after de novo renal transplantation.

Abstract

After renal transplantation, immunosuppressive regimens associated with high short-term survival rates are not necessarily associated with high long-term survival rates, suggesting that regimens may need to be optimized over time. Calcineurin inhibitor (CNI) withdrawal from a sirolimus-based immunosuppressive regimen may maximize the likelihood of long-term… (More)
DOI: 10.1681/ASN.2007040495

8 Figures and Tables

Topics

  • Presentations referencing similar topics